Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Retrolaminar block to reduce opioid use after lumbar fusion

Official title: Effectiveness of Retrolaminar Block in Reducing Postoperative Opioid Consumption in Patients Undergoing Lumbar Spine Fusion With Multimodal Analgesia

Run by Pontificia Universidad Catolica de Chile · NCT07291388 · Data updated 2026-11-12

This study tests whether an ultrasound-guided retrolaminar block can cut opioid needs after lumbar fusion when paired with multimodal pain relief.

More Acute Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment44 (estimated)
SponsorPontificia Universidad Catolica de Chile
Academic / other
Locations1 site (Santiago, Santiago Metropolitan)
StatusRecruiting
StartedJune 30, 2026
Main results expectedDecember 2026
Study endsMarch 2027
Registry record updatedJuly 6, 2026
Trial IDNCT07291388 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–75 scheduled for lumbar spine fusion, ASA I–III, who can provide informed consent.

Probably not a fit

Patients with chronic opioid use, higher surgical risk (ASA ≥4), or contraindications to regional blocks may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, blinded, controlled trial compares a retrolaminar block with 0.25% bupivacaine and epinephrine to a sham block using saline in adults undergoing lumbar spine fusion. All participants receive standardized multimodal analgesia and are followed by the Acute Pain Unit for three days to track opioid use, pain scores, recovery quality, blood loss, and complications. The study aims to determine if the regional block reduces postoperative opioid requirements and improves early recovery without added risk. Enrollment occurs after institutional approvals and informed consent, with participants assigned 1:1 to intervention or sham. The trial is conducted at Hospital Clínico Pontificia Universidad Católica de Chile with sponsorship from Pontificia Universidad Catolica de Chile.

Why it matters

Potential benefit: If successful, patients may experience less postoperative opioid use and better early recovery after lumbar fusion.

How similar studies have gone: Prior regional anesthesia approaches have shown pain and opioid-sparing benefits in spine surgery, though this exact block technique is being evaluated in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18-75 years, scheduled for lumbar spine fusion surgery by a trauma team
* American Society of Anesthesiologists (ASA) Classification I-III
* Willing and able to provide written informed consent to participate in the study.

Exclusion Criteria:

* History of chronic use of strong or weak opioids for more than 3 months.
* Diagnosis of chronic pain and treatment by a pain management team.
* ASA score greater than or equal to 4.
* Patients with prior lumbar spine surgery. Spinal instrumentation at the surgical site.
* Estimated creatinine clearance less than 60 ml/min.
* Coagulation disorder or abnormal coagulation tests.
* Infection at the surgical site.
* Weight less than 50 kg.
* Altered mental status that prevents reliable evaluation.
* Allergy to local anesthetics or analgesic drugs used in the study.
* Patients with contraindications to peripheral nerve blocks.
* Lumbar spine fixation due to oncologic disease or acute trauma.
* Use of intraoperative neuromonitoring and TIVA.

Where it's running

  • Hospital Clínico Pontificia Universidad Católica de Chile
    Santiago, Santiago Metropolitan, Chile
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.